Company

Amplia Therapeutics

As of the edition of 20 October 2026, Amplia Therapeutics runs 1 drug.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Total1

Where its trials are

  • Cancer: 2 trials led
  • Digestive system: 2 trials led
  • Hormones: 2 trials led